What is CertaScan Technologies?
CertaScan Technologies operates at the intersection of healthcare security and biometric innovation. The company specializes in LiveScan high-resolution footprint capture, a method specifically engineered to overcome the limitations of traditional infant identification. Unlike fingerprinting or iris scanning, which face physiological challenges in newborns, CertaScan provides a stable, non-invasive, and highly accurate biometric solution. The system is fully HIPAA compliant and utilizes FIPS 140-2 encryption to protect sensitive data, ensuring that hospitals can maintain rigorous security standards without compromising patient privacy. Beyond its core security function, the platform offers value-added services, including digital keepsakes for parents, which enhances the overall patient experience and hospital-family engagement.
How much funding has CertaScan Technologies raised?
CertaScan Technologies has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in CertaScan Technologies
PPP
Public-Private Partnership
What's next for CertaScan Technologies?
With this late-stage capital, CertaScan Technologies is well-positioned to accelerate its market penetration and expand its footprint within the healthcare sector. The strategic focus will likely shift toward scaling installation and maintenance services, as well as enhancing the software ecosystem that supports its hardware infrastructure. As hospitals increasingly prioritize patient safety and data integrity, CertaScan is poised to capitalize on the growing demand for specialized biometric solutions. Future growth trajectories will likely involve deeper integration with electronic health record systems and the potential expansion of its digital keepsake platform, further cementing its status as a leader in neonatal security technology.
See full CertaScan Technologies company page
